Combination of HSP90 inhibitor onalespib with crizotinib to treat or delay resistance in NSCLC: Preclinical and clinical investigations

Date 02 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Phase 1 studies: Miscellaneous drugs & targets
Topics Anticancer agents
Clinical research
Non-small-cell lung cancer
Basic Scientific Principles
Therapy
Biological therapy
Presenter Harold Keer